Perrigo confirms first to file patent challenge for generic version of Topicort®
Perrigo announced that it has filed with the FDA an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro Pharmaceuticals U.S.A., the owner of the Reference Listed Drug of its filing. July 30, 2014